Catalyst Wire Dossier Catalyst Wire Dossier

Exemestane

Exemestane · Mylan Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

102 regulatory and trial events tracked for Exemestane, covering 2008-12-18 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors [Phase 2]

See pricing